2,6-bis(1-methylethyl)phenyl ((2,4,6-tris(1-methylethyl)phenyl)acetyl)sulfamate,
avasimibe,
avasimibe sodium,
CI 1011,
CI-1011,
Avasimibe,
166518-60-1,
CI-1011,
Avasimibe(CI-1011),
UNII-28LQ20T5RC,
CI 1011,
Avasimibe (CI-1011),
PD 148515,
28LQ20T5RC,
CHEMBL101309,
2,6-Diisopropylphenyl (2-(2,4,6-triisopropylphenyl)acetyl)sulfamate,
MFCD00934956,
2,6-Diisopropylphenyl ((2,4,6-triisopropylphenyl)acetyl)sulfamate,
2,6-diisopropylphenyl 2-(2,4,6-triisopropylphenyl)acetylsulfamate,
2,6-Diisopropylphenyl (2-(2,4,6-triisopropylphenyl)-acetyl)sulfamate,
((2,4,6-Tris(1-methylethyl)phenyl)acetyl)sulfamic acid 2,6-bis(1-methylethyl)phenyl ester,
[2,6-di(propan-2-yl)phenyl] N-[2-[2,4,6-tri(propan-2-yl)phenyl]acetyl]sulfamate,
N-((2,6-Bis(1-methylethyl)phenoxy)sulfonyl)-2,4,6-tris(1-methylethyl)benzeneacetamide,
N-[(2,6-DIISOPROPYLPHENOXY)SULFONYL]-2-(2,4,6-TRIISOPROPYLPHENYL)ACETAMIDE,
Benzeneacetamide, N-((2,6-bis(1-methylethyl)phenoxy)sulfonyl)-2,4,6-tris(1-methylethyl)-,
N-((2,6-Bis(1-methylethyl)phenoxy)sulfonyl)-2,4,6-tris(1-methylethyl)-benzeneacetamide,
[[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 2,6-bis(1-methylethyl)phenyl ester] sulfamic acid,
SMR002530075,
Avasimibe [USAN],
Avasimibe [USAN:INN],
C29H43NO4S,
PubChem22420,
Avasimibe,CI-1011,
Avasimibe (USAN/INN),
AC1Q6XWY,
Avasimibe - CI-1011,
Avasimibe(CI-1011)/,
AC1L4YB3,
BIDD:PXR0029,
SCHEMBL15876,
MLS006010422,
MLS006010991,
Avasimibe, >=98% (HPLC),
DTXSID80168117,
HMS3655H08,
2,6-diisopropylphenyl[(2,4,6-triisopropylphenyl)acetyl]sulfamate,
BCP02302,
EX-A2230,
ZINC1540245,
ABP000706,
AN-534,
BDBM50069900,
CI1011,
s2187,
AKOS015913985,
BCP9000344,
CS-5695,
QC-2165,
RL02140,
SB19572,
NCGC00346572-01,
NCGC00346572-02,
4CA-0211,
AJ-26841,
AK-60856,
Avasimibe; CI-1011; PD-148515,
BC660121,
HY-13215,
LS-28486,
AB0020966,
Avasimibe;CI-1011;166518-60-1,
PD-148515,
FT-0737704,
SW219628-1,
V2056,
D03012,
S-7709,
518A601,
SR-01000944953,
J-523295,
SR-01000944953-1,
I14-44764,
(2,6-diisopropylphenyl) N-[2-(2,4,6-triisopropylphenyl)acetyl]sulfamate,
((2,4,6-tris(1-methylethyl)phenyl)acetyl)sulfamicacid2,6-bis(1-methylethyl)phenylester,
[2-(2,4,6-Triisopropyl-phenyl)-acetyl]-sulfamic acid 2,6-diisopropyl-phenyl ester,
1-[(2,6-diisopropylphenoxysulfonyl)amino]-2-(2,4,6-triisopropylphenyl)ethanone,
CI-1011; PD 148515; [[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 2,6-bis(1-methylethyl)phenyl ester] sulfamic acid,
N-[2-[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 2,6-bis(1-methylethyl)phenyl ester sulfamic acid,
Sulfamic acid, N-[2-[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 2,6-bis(1-methylethyl)phenyl ester,
Avasimibe sodium,
D0O1KX,
C29-H43-N-O4-S,
AR-1D4919,
CC-104,
CID166558,
RW3061,
A4318,
A10102,
C423185,
2,6-diisopropylphenyl[(2,4,6-triisopropylphenyl)acet-yl]-sulfamate,
2,6-bis(1-methylethyl)phenyl ((2,4,6-tris(1-methylethyl)phenyl)acetyl)sulfamate,
N-(2,6-DIPROPAN-2-YLPHENOXY)SULFONYL-2-(2,4,6-TRIPROPAN-2-YLPHENYL)ACETAMIDE,
20194-70-1,
N-[2-[2,4,6-Tris(1-methylethyl)phenyl]acetyl]sulfamic acid 2,6-bis(1-methylethyl)phenyl ester,